Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

‘Refuin’ : a Non-cytotoxic Carcinostatic Compound proliferated by a Thermophilic Actinomycete

Abstract

‘REFUIN’ is a high-molecular fraction of a fermentation beer produced by a thermophilic actinomycete. The fraction is recovered by precipitation with ammonium sulphate and by fractional ice crystallization. Although the fermentation temperature is 50° C, the active principle is heat-labile, losing all activity after 6 h at room temperature. Electrophoretic analysis reveals a ninhydrin staining positively charged band.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Tendler, M. D., Bull. Torrey Bot. Club, 86, 17 (1959). Tendler, M. D., and Burkholder, P. R., App. Microbiol., 9, 394 (1961).

    Article  Google Scholar 

  2. Moore, George E., Symp. and Panel Disc., N.Y. State J. Med., 62, 2124 (1962).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

TENDLER, M., KORMAN, S. ‘Refuin’ : a Non-cytotoxic Carcinostatic Compound proliferated by a Thermophilic Actinomycete. Nature 199, 501 (1963). https://doi.org/10.1038/199501a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/199501a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing